Case Study: Large Pharmaceutical Company achieves 2% cost savings with Mu Sigma's clinical trial outsourcing strategy

Developed an outsourcing strategy for a large pharmaceutical company to conduct effective clinical studies

Mu Sigma worked with a large pharmaceutical company facing a growing pipeline of molecules, rising clinical trial demands, and tight budget constraints. The client needed a more integrated and reliable way to manage outsourced clinical studies, since data was dispersed, quality was inconsistent, and there was little visibility into success metrics or feedback for future refinement.

Mu Sigma developed an outsourcing strategy for clinical studies, using operational grouping, KPI definition, hypothesis testing, and analytical models such as cross-correlation, regression, and time series analysis. This helped the client determine the best outsourcing models for different studies, improve project planning, and shorten timelines by 12%, while also delivering 2% cost savings through higher clinical trial productivity.